Analysis – Page 2 – Goldea Capital

Clairvest Reports Fiscal 2027 First Quarter Results

Written by Customer Service on August 14, 2026. Posted in Earnings Releases And Operating Results.

TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2027 first quarter ended June 30, 2026 and events which occurred subsequent to quarter end. (All figures are in Canadian dollars unless otherwise stated) HighlightsJune 30, 2026 book value was $1.328 billion or $99.26 per share compared with $1.293 billion or $96.60 per share as at March 31, 2026, up 3.8% in the quarter inclusive of the dividends accrued and paid subsequent to quarter end Net income for the quarter ended June 30, 2026 was $48.4 million or $3.61 per share During the quarter, Clairvest and Clairvest Equity Partners VI (“CEP VI”) completed the sale of their interest in Star Waste Systems, LLC (“Star Waste”), realizing total proceeds of US$138.6 million, or a 2.6x multiple on invested capital Also during...

ArrowMark Financial Corp. Announces Monthly Cash Distribution of $0.15 per Share for August 2026

Written by Customer Service on August 14, 2026. Posted in Dividend Reports And Estimates.

DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) — ArrowMark Financial Corp. (Nasdaq: BANX) (“ArrowMark Financial” or the “Company”), an SEC registered closed-end management investment company, today announced that its Board of Directors has declared a monthly cash distribution of $0.15 per share for August 2026. The total distribution of $0.15 per share will be payable on August 31, 2026, to shareholders of record on August 24, 2026. About ArrowMark Financial Corp.ArrowMark Financial Corp. is an SEC registered non-diversified, closed-end fund listed on the NASDAQ Global Select Market under the symbol “BANX.” Its investment objective is to provide shareholders with current income. The Fund pursues its objective by investing primarily in regulatory capital securities of financial institutions. ArrowMark Financial is...

Peyto Exploration & Development Corp. Confirms Monthly Dividend for September 15, 2026

Written by Customer Service on August 14, 2026. Posted in Dividend Reports And Estimates.

CALGARY, Alberta, Aug. 14, 2026 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to August 2026 of $0.12 per common share is to be paid on September 15, 2026, for shareholders of record on August 31, 2026. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the President and CEO and includes estimates of monthly capital expenditures and production. For further information please contact:Jean-Paul LachancePresident...

Erdene Announces Q2 2026 Results

Written by Customer Service on August 14, 2026. Posted in Earnings Releases And Operating Results.

Q2 2026 Highlights:Bayan Khundii Gold Mine produced and sold 11,709 ounces gold at an average price of US$4,493/oz for US$53M in gross revenues Operated Bayan Khundii at 94% of target throughput and recovered 96% of gold, exceeding expectations Advanced preliminary economic assessment for Zuun Mod molybdenum-copper porphyry project with results expected in mid-H2 2026 Completed maiden drill program at Tereg Uul near Oyu Tolgoi intersecting anomalous gold and silver along a 1.5 kilometre mineralized structure HALIFAX, Nova Scotia, Aug. 14, 2026 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQX: ERDCF) (“Erdene” or the “Company”) is pleased to announce operating and financial results for the three and six months ended June 30, 2026, and to provide an update on the Bayan Khundii...

BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update

Written by Customer Service on August 14, 2026. Posted in Earnings Releases And Operating Results.

ASCO 2026 Data Demonstrate Long-term Survival Benefit of Plinabulin/Docetaxel and Pembrolizumab in Metastatic NSCLC Following Progression on First-Line Immune Checkpoint Inhibitor (ICI) Therapy AACR 2026 Preclinical Data Provide the Scientific Rationale for Plinabulin as a Potential Backbone Agent to Combine with Antibody-Drug Conjugate (ADC) Regimens to Improve Efficacy, Survival and Tolerability Leadership Transition Effective July 1, 2026 Aligns the Organization Around Focused Advancement of the Confirmatory DUBLIN-4 Program in NSCLC Post-ICI and Long-Term Value Creation FLORHAM PARK, N.J., Aug. 14, 2026 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and other diseases, today announced its financial...

Streamex Corp. Reports Second Quarter 2026 Financial Results

Written by Customer Service on August 14, 2026. Posted in Earnings Releases And Operating Results.

WINTER PARK, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, today reported financial results for the second quarter ended June 30, 2026. Management will host a business and quarterly update call Monday, August 17, at 4:30 p.m. ET to discuss the results, provide a business update, introduce GLDC, and outline the Company’s product roadmap and growth strategy. Streamex Q2 2026 Business & Quarterly Update Call Details Management will host a conference call and webcast on Monday, August 17, 2026, at 4:30 p.m. ET to discuss the Company’s Q2 2026 financial results and provide a business update. United States (New York): (646) 307-1952USA & Canada Toll-Free: (888) 672-2415Passcode: 3457683Webcast:...

Optimi Health Establishes Discretionary Equity Facility

Written by Customer Service on August 14, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “Purchase Agreement”) with Seven Knots, LLC (“Seven Knots”), establishing an equity line of credit (the “ELOC”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility. Sales under the ELOC are at the Company’s discretion, subject to the terms and conditions of the Purchase Agreement. For each draw, Seven Knots is obligated to purchase the shares specified in the Company’s purchase notice...

PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

Written by Customer Service on August 14, 2026. Posted in Public Companies.

MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported financial and operational results for the first quarter of its fiscal year ended June 30, 2026. PetVivo will hold a conference call today at 5:00 p.m. Eastern time to discuss the results and provide a business update, followed by a question-and-answer period (see dial-in information below). Fiscal Q1 2027 Operational HighlightsAnnounced the acquisition of PiezoBioMembrane (PBM), PetVivo’s existing R&D partner and developer of functional biomaterials and piezoelectric technologies invented at the University of Connecticut...

Diana Shipping Inc. Withdraws Offer to Acquire Genco Shipping & Trading Following Genco Board’s Outrageous Demands

Written by Customer Service on August 14, 2026. Posted in Mergers And Acquisitions.

Following Nine Months of Avoiding Engagement, Genco Board Demands Consideration Valued at Approximately $36.91 Per Share — a 57% Premium to Genco’s Undisturbed Share Price at the Time of Diana’s Last Offer Genco’s Demands Are Completely Disconnected from the Reality of What a Credible Buyer Could Reasonably Be Expected to Pay Shareholders Should Question Whose Interests Their Board Is Actually Serving By Making Demands That Can’t Possibly Be Met, Shareholders are Effectively Being Prevented from Realizing an Attractive Premium, As Board Makes its Misalignment with Shareholders and Primary Focus on its Personal Interests Crystal Clear Diana Remains Genco’s Largest Shareholder and Will Continue to Raise These Issues and Hold the Board Accountable for Every Commitment It Has Made. ATHENS, Greece, Aug. 14, 2026 (GLOBE NEWSWIRE) —...

Maui Land & Pineapple Company, Inc. Reports Fiscal Second Quarter 2026 Results

Written by Customer Service on August 14, 2026. Posted in Earnings Releases And Operating Results.

KAPALUA, Hawai‘i, Aug. 14, 2026 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results for the six months ended June 30, 2026. The first half of the year was a period of steady progress for the Company. Its commercial real estate and land leasing businesses continued to generate dependable, recurring revenue totaling approximately $6.6 million for the six months ended June 30, 2026. The Company continued to invest across its business units including its development projects, agricultural ventures, and infrastructure facilities which will continue to build long-term value for the Company. “Our commercial real estate and land leasing businesses continue to provide a stable foundation, and we are reinvesting that stability into a development pipeline we believe will produce meaningful...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals